文献速递腹部MR

肝脏影像报告和数据系统2018版在酒精性肝硬化与病毒相关肝硬化中诊断肝细胞癌的比较

Liver Imaging Reporting and Data System version 2018 for diagnosing hepatocellular carcinoma in alcoholic liver cirrhosis and virus-related cirrhosis.
PubMed 文献 · Eur J Radiol · 2023-10-06

回顾性纳入酒精性肝硬化(ALC)38例、丙型肝炎病毒相关肝硬化(HCV)37例及按年龄、病灶大小、Child-Pugh分级1:1匹配的乙型肝炎病毒相关肝硬化(HBV)患者,评估钆塞酸增强MRI上LI-RADS v2018对≤3.0 cm肝细胞癌的诊断效能;ALC组敏感度显著低于HBV组(52.6% vs 88.6%,p<.001),HCV与HBV组间无显著差异;ALC组中肝胆期低信号提供显著更高的敏感度(76.3% vs 52.6%,p=.008)。

要点

  • ALC组LI-RADS诊断≤3.0 cm HCC的敏感度显著低于HBV组(52.6% vs 88.6%,p<.001)。
  • ALC组肝胆期低信号敏感度显著高于LI-RADS整体标准(76.3% vs 52.6%,p=.008)。
  • HCV与HBV组间LI-RADS诊断效能无显著差异。

核心结论

  • LI-RADS v2018在钆塞酸增强MRI上诊断≤3.0 cm HCC的敏感度在酒精性肝硬化组显著低于HBV相关肝硬化组,HCV与HBV组间无显著差异;ALC组中肝胆期低信号可提供更高敏感度。

研究设计与样本

  • 回顾性纳入38例酒精性肝硬化(ALC)和37例丙型肝炎病毒相关肝硬化(HCV)患者,均行术前钆塞酸增强MRI并接受手术切除或移植;HBV相关肝硬化患者按年龄、病灶大小、Child-Pugh分级与HCV组和ALC组1:1匹配纳入作为比较组。

关键影像表现/征象

  • ALC组肝脂肪变性频率显著高于HBV组(25.8% vs 6.1%,p=.04)。
  • ALC组HCC门静脉期非周边廓清频率显著低于HBV组(63.2% vs 97.1%,p<.001)。

诊断标准与关键数值

  • ALC组LI-RADS诊断≤3.0 cm HCC的敏感度为52.6%,HBV组为88.6%,两组差异显著(p<.001)。
  • HCV组与HBV组间LI-RADS诊断效能无显著差异。
  • ALC组中肝胆期低信号诊断HCC的敏感度为76.3%,显著高于LI-RADS标准的52.6%(p=.008)。

临床应用与阅片要点

  • 在酒精性肝硬化患者中应用LI-RADS v2018诊断≤3.0 cm HCC时,敏感度可能低于HBV相关肝硬化患者。
  • 酒精性肝硬化患者HCC门静脉期非周边廓清出现频率较低,阅片时需结合肝胆期低信号等征象。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We aimed to evaluate and compare the diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2018 for hepatocellular carcinoma (HCC) ≤ 3.0 cm on gadoxetic acid-enhanced MRI according to the etiology of cirrhosis.

METHODS: Thirty-eight patients with alcoholic liver cirrhosis (ALC) and 37 with hepatitis C virus-related cirrhosis (HCV) who underwent preoperative MRI and subsequent surgical resection or transplantation were included. For comparison groups, patients with hepatitis B virus-related cirrhosis (HBV) were included by 1:1 matching with HCV and ALC groups according to age, lesion size, and Child-Pugh classification. The imaging characteristics of background liver and focal lesions were analyzed. The diagnostic performance of LI-RADS was compared between HCV and HBV groups, and between ALC and HBV groups.

RESULTS: ALC group showed significantly higher frequency of hepatic steatosis (25.8 % vs. 6.1 %, p =.04) and lower frequency of nonperipheral washout on portal venous-phase in HCC (63.2 % vs. 97.1 %, p <.001) compared with HBV group. ALC group showed significantly lower sensitivity than HBV group (52.6 % vs. 88.6 %, p<.001). No significant differences in diagnostic performance were found between HCV and HBV groups. In ALC group, hepatobiliary-phase hypointensity provided significantly higher sensitivity (76.3 % vs. 52.6 %, p =.008).

CONCLUSION: The sensitivity of LI-RADS for diagnosing HCC ≤ 3.0 cm was significantly lower in the ALC group than in the HBV group.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Choi JY, Choi SH, Byun JH, et al. Liver Imaging Reporting and Data System version 2018 for diagnosing hepatocellular carcinoma in alcoholic liver cirrhosis and virus-related cirrhosis. Eur J Radiol. 2023. PMID: 37856941. doi:10.1016/j.ejrad.2023.111139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。